Dronabinol increases pain threshold compared to placebo for functional chest pain over 4 weeks
Dronabinol increases pain threshold compared to placebo for functional chest pain over 4 weeks
Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial
Dis Esophagus. 2017 Feb 1;30(2):1-8. doi: 10.1111/dote.12455Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Thirteen patients with non-cardiac functional chest pain were randomized to receive 5 mg capsules of dronabinol or placebo twice daily for 4 weeks. Patients described their chest pain episodes, completed the Short Form-36 (SF-36), Beck Anxiety Inventory and Beck Depression Inventory, and rated their pain during esophageal balloon distention tests (EBDT) to determine if dronabinol increased pain th...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.